$WTMA
Welsbach Technology Metals Acquisition Corp Stock $wtma

$wtma Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024043149 Filed on May 15, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$322.0K	$908.3K
YoY Change	-64.55%	57.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$322.0K	$908.3K
YoY Change	-64.55%	57.41%
Operating Profit	-$322.0K	-$908.3K
YoY Change	-64.55%
Interest Expense	$260.7K	$845.1K
YoY Change	-69.15%	10762.34%
% of Operating Profit
Other Income/Expense, Net	$260.7K	$845.1K
YoY Change	-69.15%	10766.53%
Pretax Income	-$61.31K	-$63.23K
YoY Change	-3.03%	-88.89%
Income Tax	$8.849K	$167.0K
% Of Pretax Income
Net Earnings	-$70.16K	-$230.2K
YoY Change	-69.52%	-59.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding		10.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.760K	$137.6K
YoY Change	-95.09%	-84.72%
Cash & Equivalents	$6.760K	$350.8K
Short-Term Investments
Other Short-Term Assets	$0.00	$78.31K
YoY Change	-100.0%	-69.98%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$6.760K	$215.9K
YoY Change	-96.87%	-81.41%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles		$5.000M
YoY Change
Long-Term Investments	$24.03M	$80.62M
YoY Change	-70.19%	4.31%
Other Assets	$161.5K	$213.2K
YoY Change	-24.27%
Total Long-Term Assets	$24.19M	$80.83M
YoY Change	-70.07%	4.59%
TOTAL ASSETS
Total Short-Term Assets	$6.760K	$215.9K
Total Long-Term Assets	$24.19M	$80.83M
Total Assets	$24.20M	$81.04M
YoY Change	-70.14%	3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.701M	$2.552M
YoY Change	5.86%	13691.99%
Accrued Expenses	$130.0K	$215.8K
YoY Change	-39.77%	94.89%
Deferred Revenue
YoY Change
Short-Term Debt	$3.219M	$1.671M
YoY Change	92.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.979M	$47.63M
YoY Change	-85.35%	13693.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.705M	$2.705M
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$2.705M	$2.705M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.979M	$47.63M
Total Long-Term Liabilities	$2.705M	$2.705M
Total Liabilities	$9.683M	$50.34M
YoY Change	-80.76%	1550.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.525M	-$6.921M
YoY Change	37.64%
Common Stock	$228.00	$228.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.525M	-$6.921M
YoY Change
Total Liabilities & Shareholders Equity	$24.20M	$81.04M
YoY Change	-70.14%	3.31%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$70.16K	-$230.2K
YoY Change	-69.52%	-59.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$373.7K	$42.46M
YoY Change	-100.88%	-14235.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$125.0K
YoY Change	-100.0%	-105.49%
Cash From Investing Activities		-$125.0K
YoY Change		-94.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$373.7K	-$42.51M
YoY Change	-100.88%	-1967.12%
NET CHANGE
Cash From Operating Activities	-$373.7K	$42.46M
Cash From Investing Activities		-$125.0K
Cash From Financing Activities	$373.7K	-$42.51M
Net Change In Cash	$0.00	-$172.3K
YoY Change	-100.0%	-42.65%
FREE CASH FLOW
Cash From Operating Activities	-$373.7K	$42.46M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1006702
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41183
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Welsbach Technology Metals Acquisition Corp.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4422 N. Ravenswood Ave #1025
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60640
CY2024Q1	dei	City Area Code CityAreaCode	+1 (251)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	-280-1980
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	373737	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-42511600	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	523063	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350778	usd
CY2024Q1	us-gaap	Cash Cash	6760	usd
CY2023Q1	us-gaap	Cash Cash	137596	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	161449	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	213182	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350778	usd
CY2024Q1	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	189223	usd
CY2023Q1	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	750670	usd
CY2023	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1125000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.50	pure
CY2023Q4	us-gaap	Share Price SharePrice	10
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5000001	usd
CY2023	wtma	Common Stock Percentage CommonStockPercentage	0.20	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2023	wtma	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022Q3	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	772769	usd
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	true
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4456827	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6760	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6760	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	833	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6760	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7593	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	161449	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	161449	usd
CY2024Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	24029910	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	23769229	usd
CY2024Q1	us-gaap	Assets Assets	24198119	usd
CY2023Q4	us-gaap	Assets Assets	23938271	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2700939	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2846126	usd
CY2024Q1	wtma	Franchise Tax Payable Current FranchiseTaxPayableCurrent	130000	usd
CY2023Q4	wtma	Franchise Tax Payable Current FranchiseTaxPayableCurrent	80000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	21458	usd
CY2024Q1	wtma	Excise Tax Payable ExciseTaxPayable	583520	usd
CY2023Q4	wtma	Excise Tax Payable ExciseTaxPayable	583520	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6978788	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6648780	usd
CY2024Q1	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2023Q4	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2024Q1	us-gaap	Liabilities Liabilities	9683478	usd
CY2023Q4	us-gaap	Liabilities Liabilities	9353470	usd
CY2024Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2024Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.06
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.98
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	24039901	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	23850678	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2283976	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	228	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9525488	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9266105	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9525260	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9265877	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24198119	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23938271	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	271992	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	858322	usd
CY2024Q1	wtma	Franchise Tax FranchiseTax	50000	usd
CY2023Q1	wtma	Franchise Tax FranchiseTax	50000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-321992	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-908322	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	260681	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	845090	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	260681	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	845090	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-61311	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63232	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8849	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166969	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-70160	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230201	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9265877	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	189223	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-70160	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9525260	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5939636	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	750670	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230201	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6920507	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-70160	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230201	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	260681	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	845090	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-833	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	53306	usd
CY2023Q1	wtma	Increase Decrease In Due To Stockholders For Redemption Of Common Stock IncreaseDecreaseInDueToStockholdersForRedemptionOfCommonStock	42636600	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	30000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	4000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-145187	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	732892	usd
CY2024Q1	wtma	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	50000	usd
CY2023Q1	wtma	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	52451	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	21458	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	166969	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-373737	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42464315	usd
CY2023Q1	us-gaap	Payments To Invest In Decommissioning Fund PaymentsToInvestInDecommissioningFund	125000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125000	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	373737	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	125000	usd
CY2023Q1	wtma	Payment To Redeem Common Stock PaymentToRedeemCommonStock	42636600	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	373737	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-42511600	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-172285	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	523063	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350778	usd
CY2024Q1	us-gaap	Cash Cash	6760	usd
CY2023Q1	us-gaap	Cash Cash	137596	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	161449	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	213182	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168209	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350778	usd
CY2024Q1	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	189223	usd
CY2023Q1	wtma	Accretion For Redeemable Common Stock To Redemption Value AccretionForRedeemableCommonStockToRedemptionValue	750670	usd
CY2023	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1125000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.50	pure
CY2023Q4	us-gaap	Share Price SharePrice	10
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5000001	usd
CY2023	wtma	Common Stock Percentage CommonStockPercentage	0.20	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2023	wtma	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022Q3	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	772769	usd
CY2022Q4	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	772769	usd
CY2023Q1	us-gaap	Payments For Deposits PaymentsForDeposits	125000	usd
CY2023Q1	us-gaap	Share Price SharePrice	10
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4097964	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.4
CY2023Q1	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	42600000	usd
CY2023Q2	wtma	Shares Exercising Price SharesExercisingPrice	42600000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1456871	shares
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.79
CY2023Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	15700000	usd
CY2022Q3	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023Q1	wtma	Stockholders Redeemed Common Shares stockholdersRedeemedCommonShares	4097964	shares
CY2023Q3	wtma	Stockholders Redeemed Common Shares stockholdersRedeemedCommonShares	1456871	shares
CY2023Q1	us-gaap	Payable Common Stock Redeemed PayableCommonStockRedeemed	42636600	usd
CY2023Q3	us-gaap	Payable Common Stock Redeemed PayableCommonStockRedeemed	15715387	usd
CY2023Q1	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	583520	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6760	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	161449	usd
CY2023Q4	wtma	Working Capital Amount WorkingCapitalAmount	6972028	usd
CY2023	wtma	Financial Term FinancialTerm	P1Y
CY2022Q4	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	772769	usd
CY2023Q1	us-gaap	Payments For Deposits PaymentsForDeposits	125000	usd
CY2023Q1	us-gaap	Share Price SharePrice	10
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4097964	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.4
CY2023Q1	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	42600000	usd
CY2023Q2	wtma	Shares Exercising Price SharesExercisingPrice	42600000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1456871	shares
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.79
CY2022Q3	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023Q1	wtma	Stockholders Redeemed Common Shares stockholdersRedeemedCommonShares	4097964	shares
CY2023Q3	wtma	Stockholders Redeemed Common Shares stockholdersRedeemedCommonShares	1456871	shares
CY2023Q1	us-gaap	Payable Common Stock Redeemed PayableCommonStockRedeemed	42636600	usd
CY2023Q3	us-gaap	Payable Common Stock Redeemed PayableCommonStockRedeemed	15715387	usd
CY2023Q1	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023	wtma	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	583520	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6760	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	161449	usd
CY2023Q4	wtma	Working Capital Amount WorkingCapitalAmount	6972028	usd
CY2023	wtma	Financial Term FinancialTerm	P1Y
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p>
CY2023	wtma	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	58351987	usd
CY2022Q4	wtma	Payment Of Franchise Taxes PaymentOfFranchiseTaxes	85232	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	213182	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	142851	usd
CY2024Q1	wtma	Withdrawn Trust Account For Taxes WithdrawnTrustAccountForTaxes	741013	usd
CY2024Q1	wtma	Franchise And Income Taxes FranchiseAndIncomeTaxes	579564	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	161449	usd
CY2022Q4	wtma	Payment Of Franchise Taxes PaymentOfFranchiseTaxes	85232	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	213182	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	142851	usd
CY2024Q1	wtma	Withdrawn Trust Account For Taxes WithdrawnTrustAccountForTaxes	741013	usd
CY2024Q1	wtma	Offering Costs Associated With The Ipo And Overallotment OfferingCostsAssociatedWithTheIPOAndOverallotment	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Offering Costs associated with the IPO and over-allotment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs of the IPO amounted to $4,663,218, which was charged against additional paid-in capital and common stock subject to redemption upon the completion of the IPO. Subsequently, additional offering cost of $125,228 was incurred with the Over-allotment in January 2022 and was also charged against additional paid-in capital and common stock subject to redemption in January 2022.</p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of March 31, 2024, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p>
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1443	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.6406	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	wtma	Offering Costs Associated With The Ipo And Overallotment OfferingCostsAssociatedWithTheIPOAndOverallotment	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Offering Costs associated with the IPO and over-allotment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Offering costs consist principally of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs of the IPO amounted to $4,663,218, which was charged against additional paid-in capital and common stock subject to redemption upon the completion of the IPO. Subsequently, additional offering cost of $125,228 was incurred with the Over-allotment in January 2022 and was also charged against additional paid-in capital and common stock subject to redemption in January 2022.</p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of March 31, 2024, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p>
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1443	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.6406	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	4097964	shares
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	4097964	shares
CY2023Q1	wtma	Aggregate Redemption Amount AggregateRedemptionAmount	42600000	usd
CY2023Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	1456871	usd
CY2023Q3	wtma	Aggregate Redemption Amount AggregateRedemptionAmount	15700000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	23850678	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	189223	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	24039901	usd
CY2023Q1	wtma	Aggregate Redemption Amount AggregateRedemptionAmount	42600000	usd
CY2023Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	1456871	usd
CY2023Q3	wtma	Aggregate Redemption Amount AggregateRedemptionAmount	15700000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	23850678	usd
CY2024Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	189223	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	24039901	usd
CY2024Q1	wtma	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2024Q1	wtma	Number Of Shares Right To Receive NumberOfSharesRightToReceive	1	shares
CY2024Q1	wtma	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2024Q1	wtma	Number Of Shares Right To Receive NumberOfSharesRightToReceive	1	shares
CY2024Q1	wtma	Number Of Shares Right To Receive NumberOfSharesRightToReceive	1	shares
CY2022Q1	wtma	Aggregate Purchase Price AggregatePurchasePrice	45540	usd
CY2024Q1	wtma	Limited Exception LimitedException	0.50	pure
CY2024Q1	wtma	Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays	P20D
CY2024Q1	wtma	Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays	P30D
CY2022Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	259136	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	30000	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	120000	usd
CY2023	wtma	Due To Affiliates DueToAffiliates	88000	usd
CY2023	us-gaap	Sponsor Fees SponsorFees	6000	usd
CY2023	wtma	Accrued Services AccruedServices	26000	usd
CY2024Q1	wtma	Working Capital Loans WorkingCapitalLoans	1500000	usd
CY2024Q1	wtma	Balance Outstanding Working Capital Notes BalanceOutstandingWorkingCapitalNotes	922837	usd
CY2023	wtma	Balance Outstanding Working Capital Notes BalanceOutstandingWorkingCapitalNotes	549100	usd
CY2024Q1	wtma	Balance Outstanding Promisorry Note BalanceOutstandingPromisorryNote	2296371	usd
CY2023	wtma	Balance Outstanding Promisorry Note BalanceOutstandingPromisorryNote	2296371	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	3219208	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2845471	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	10000	usd
CY2024Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	30000	usd
CY2023Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	30000	usd
CY2024Q1	wtma	Underwriting Fee Per Unit UnderwritingFeePerUnit	0.2
CY2024Q1	wtma	Sale Of Stock Underwriting Fees SaleOfStockUnderwritingFees	1545537	usd
CY2024Q1	wtma	Additional Underwriting Payable Per Share AdditionalUnderwritingPayablePerShare	0.35
CY2024Q1	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2023Q3	us-gaap	Net Shares Reclassified To Mandatorily Redeemable Capital Stock Shares NetSharesReclassifiedToMandatorilyRedeemableCapitalStockShares	2432185	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	500000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100000	shares
CY2024Q1	wtma	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2024Q1	wtma	Number Of Shares Right To Receive NumberOfSharesRightToReceive	1	shares
CY2022Q1	wtma	Aggregate Purchase Price AggregatePurchasePrice	45540	usd
CY2024Q1	wtma	Limited Exception LimitedException	0.50	pure
CY2024Q1	wtma	Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Trading Days TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays	P20D
CY2024Q1	wtma	Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination Threshold Consecutive Trading Days TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays	P30D
CY2022Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	259136	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	30000	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	120000	usd
CY2023	wtma	Due To Affiliates DueToAffiliates	88000	usd
CY2023	us-gaap	Sponsor Fees SponsorFees	6000	usd
CY2023	wtma	Accrued Services AccruedServices	26000	usd
CY2024Q1	wtma	Working Capital Loans WorkingCapitalLoans	1500000	usd
CY2024Q1	wtma	Balance Outstanding Working Capital Notes BalanceOutstandingWorkingCapitalNotes	922837	usd
CY2024Q1	wtma	Balance Outstanding Promisorry Note BalanceOutstandingPromisorryNote	2296371	usd
CY2023	wtma	Balance Outstanding Promisorry Note BalanceOutstandingPromisorryNote	2296371	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2845471	usd
CY2021Q4	us-gaap	Sponsor Fees SponsorFees	10000	usd
CY2024Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	30000	usd
CY2023Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	30000	usd
CY2024Q1	wtma	Underwriting Fee Per Unit UnderwritingFeePerUnit	0.2
CY2024Q1	wtma	Sale Of Stock Underwriting Fees SaleOfStockUnderwritingFees	1545537	usd
CY2024Q1	wtma	Additional Underwriting Payable Per Share AdditionalUnderwritingPayablePerShare	0.35
CY2024Q1	wtma	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	2704690	usd
CY2023Q3	us-gaap	Net Shares Reclassified To Mandatorily Redeemable Capital Stock Shares NetSharesReclassifiedToMandatorilyRedeemableCapitalStockShares	2432185	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	500000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2024Q1	wtma	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	58351987	usd
CY2024Q1	wtma	Interest Earned On The Trust Account InterestEarnedOnTheTrustAccount	1391640	usd
CY2024Q1	wtma	Interest Earned On Trust Account To Pay Franchise And Income Taxes InterestEarnedOnTrustAccountToPayFranchiseAndIncomeTaxes	741013	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	161449	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2024Q1	wtma	Increase Decrease In Due To Stockholders For Redemption Of Common Stock IncreaseDecreaseInDueToStockholdersForRedemptionOfCommonStock		usd
CY2024Q1	us-gaap	Payments To Invest In Decommissioning Fund PaymentsToInvestInDecommissioningFund		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q1	wtma	Payment To Redeem Common Stock PaymentToRedeemCommonStock		usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2283976	shares
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2172851	shares
CY2024Q1	wtma	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	58351987	usd
CY2024Q1	wtma	Interest Earned On Trust Account To Pay Franchise And Income Taxes InterestEarnedOnTrustAccountToPayFranchiseAndIncomeTaxes	741013	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	161449	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	wtma	Increase Decrease In Due To Stockholders For Redemption Of Common Stock IncreaseDecreaseInDueToStockholdersForRedemptionOfCommonStock		usd
CY2024Q1	us-gaap	Payments To Invest In Decommissioning Fund PaymentsToInvestInDecommissioningFund		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001866226
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001866226

Files In Submission

Name	View Source	Status
0001213900-24-043149-index-headers.html	Edgar Link	pending
0001213900-24-043149-index.html	Edgar Link	pending
0001213900-24-043149.txt	Edgar Link	pending
0001213900-24-043149-xbrl.zip	Edgar Link	pending
ea0206033-10q_welsbach.htm	Edgar Link	pending
ea020603301ex31-1_welsbach.htm	Edgar Link	pending
ea020603301ex31-2_welsbach.htm	Edgar Link	pending
ea020603301ex32-1_welsbach.htm	Edgar Link	pending
ea020603301ex32-2_welsbach.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wtma-20240331.xsd	Edgar Link	pending
wtma-20240331_cal.xml	Edgar Link	unprocessable
wtma-20240331_def.xml	Edgar Link	unprocessable
wtma-20240331_lab.xml	Edgar Link	unprocessable
wtma-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0206033-10q_welsbach_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WTMA
Welsbach Technology Metals Acquisition Corp Stock $wtma

2024 Q1 Form 10-Q Financial Statement

#000121390024043149 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTMA Welsbach Technology Metals Acquisition Corp Stock $wtma

2024 Q1 Form 10-Q Financial Statement

#000121390024043149 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTMA
Welsbach Technology Metals Acquisition Corp Stock $wtma